Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.670
-0.020 (-1.18%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Century Therapeutics Employees
Century Therapeutics had 78 employees as of December 31, 2025. The number of employees decreased by 72 or -48.00% compared to the previous year.
Employees
78
Change (1Y)
-72
Growth (1Y)
-48.00%
Revenue / Employee
n/a
Profits / Employee
-$1,407,615
Market Cap
302.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 78 | -72 | -48.00% | 78 | 0 |
| Dec 31, 2024 | 150 | -15 | -9.09% | 140 | 10 |
| Dec 31, 2023 | 165 | -19 | -10.33% | 152 | 13 |
| Dec 31, 2022 | 184 | -4 | -2.13% | 163 | 21 |
| Dec 31, 2021 | 188 | 81 | 75.70% | 170 | 18 |
| Jun 30, 2021 | 121 | - | - | 121 | 0 |
| Mar 31, 2021 | 107 | - | - | 97 | 10 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Abeona Therapeutics | 226 |
| EyePoint | 214 |
| Rocket Pharmaceuticals | 202 |
| BridgeBio Oncology Therapeutics | 88 |
| SAB Biotherapeutics | 86 |
| Upstream Bio | 75 |
| Larimar Therapeutics | 71 |
IPSC News
- 18 days ago - Century Therapeutics Appoints Joseph Truitt to Board of Directors - GlobeNewsWire
- 6 weeks ago - Century Therapeutics reports Q2 EPS (17c), consensus (12c) - TheFly
- 6 weeks ago - Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 6 weeks ago - Century Therapeutics Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Century Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - IHI Power Services Corp. Rebrands as Kyuden Energy Partners Following Acquisition by Japan's Kyuden Group - Business Wire
- 2 months ago - Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026 - GlobeNewsWire
- 3 months ago - Century Therapeutics presents new preclinical data for CNTY-813 - TheFly